121 related articles for article (PubMed ID: 35074497)
41.
Hu B; Xian Z; Zou Q; Zhang D; Su D; Yao J; Ren D
Cancer Biother Radiopharm; 2021 Feb; 36(1):45-57. PubMed ID: 32379550
[No Abstract] [Full Text] [Related]
42. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
Hu F; He Z; Sun C; Rong D
Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
[TBL] [Abstract][Full Text] [Related]
43. Up-frameshift Protein 1 Promotes Tumor Progression by Regulating Apoptosis and Epithelial-Mesenchymal Transition of Colorectal Cancer.
Chen B; Wang H; Li D; Lin X; Ma Z; Zeng Y
Technol Cancer Res Treat; 2021; 20():15330338211064438. PubMed ID: 34939866
[No Abstract] [Full Text] [Related]
44. Knockdown of FOXK1 alone or in combination with apoptosis-inducing 5-FU inhibits cell growth in colorectal cancer.
Wu Y; Xie R; Liu X; Wang J; Peng Y; Tang W; Wu M; Zhang P; Ba Y; Zhao J; Li A; Nan Q; Chen Y; Liu S; Wang J
Oncol Rep; 2016 Oct; 36(4):2151-9. PubMed ID: 27571921
[TBL] [Abstract][Full Text] [Related]
45. RNAi-mediated downregulation of DNA binding protein A inhibits tumorigenesis in colorectal cancer.
Liu RT; Wang GR; Liu C; Qiu J; Yan LK; Li XJ; Wang XQ
Int J Mol Med; 2016 Sep; 38(3):703-12. PubMed ID: 27430286
[TBL] [Abstract][Full Text] [Related]
46. Circular RNA hsa_circ_0064559 affects tumor cell growth and progression of colorectal cancer.
Zhen Y; Sun G; Chen C; Li J; Xiao R; Xu Z
World J Surg Oncol; 2023 Jun; 21(1):171. PubMed ID: 37280630
[TBL] [Abstract][Full Text] [Related]
47. Whole Exome Sequencing Identifies PHF14 Mutations in Neurocytoma and Predicts Responsivity to the PDGFR Inhibitor Sunitinib.
Zhang D; Yong W; Movassaghi M; Rodriguez FJ; Yang I; McKeever P; Qian J; Li JY; Mao Q; Newell KL; Green RM; Welsh CT; Heaney AP
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359362
[TBL] [Abstract][Full Text] [Related]
48. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer.
Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J
J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036
[TBL] [Abstract][Full Text] [Related]
49. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.
Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K
Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757
[TBL] [Abstract][Full Text] [Related]
50. PDRG1 predicts a poor prognosis and facilitates the proliferation and metastasis of colorectal cancer.
Xu Y; Liu J; Jiang T; Shi L; Shang L; Song J; Li L
Exp Cell Res; 2021 Dec; 409(2):112924. PubMed ID: 34780783
[TBL] [Abstract][Full Text] [Related]
51. Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis.
Taha-Mehlitz S; Bianco G; Coto-Llerena M; Kancherla V; Bantug GR; Gallon J; Ercan C; Panebianco F; Eppenberger-Castori S; von Strauss M; Staubli S; Bolli M; Peterli R; Matter MS; Terracciano LM; von Flüe M; Ng CKY; Soysal SD; Kollmar O; Piscuoglio S
Theranostics; 2021; 11(9):4011-4029. PubMed ID: 33754045
[No Abstract] [Full Text] [Related]
52. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
[No Abstract] [Full Text] [Related]
53. Corrigendum to "PHF14 knockdown causes apoptosis by inducing DNA damage and impairing the activity of the damage response complex in colorectal cancer" [Cancer Lett. 531 (2022) 109-123].
Pan G; Zhang K; Geng S; Lan C; Hu X; Li C; Ji H; Li C; Hu X; Wang Y; Lv M; Cui H
Cancer Lett; 2023 Aug; 568():216290. PubMed ID: 37438200
[No Abstract] [Full Text] [Related]
54. Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer.
Xiang S; Xiang T; Xiao Q; Li Y; Shao B; Luo T
Int J Oncol; 2017 Sep; 51(3):801-811. PubMed ID: 28677721
[TBL] [Abstract][Full Text] [Related]
55. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level.
Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F
Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187
[TBL] [Abstract][Full Text] [Related]
56. Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer.
Christensen LL; Holm A; Rantala J; Kallioniemi O; Rasmussen MH; Ostenfeld MS; Dagnaes-Hansen F; Øster B; Schepeler T; Tobiasen H; Thorsen K; Sieber OM; Gibbs P; Lamy P; Hansen TF; Jakobsen A; Riising EM; Helin K; Lubinski J; Hagemann-Madsen R; Laurberg S; Ørntoft TF; Andersen CL
PLoS One; 2014; 9(6):e96767. PubMed ID: 24892549
[TBL] [Abstract][Full Text] [Related]
57. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling.
Zhu Z; Hou Q; Guo H
Exp Cell Res; 2020 Dec; 397(1):112311. PubMed ID: 32991874
[TBL] [Abstract][Full Text] [Related]
58. SPZ1 promotes deregulation of Bim to boost apoptosis resistance in colorectal cancer.
Liu XY; Zheng CB; Wang T; Xu J; Zhang M; Gou LS; Jin L; Qi X; Zeng X; Li H; Qiu S; Zhang P
Clin Sci (Lond); 2020 Jan; 134(2):155-167. PubMed ID: 31934723
[TBL] [Abstract][Full Text] [Related]
59. MiR-451a suppressing BAP31 can inhibit proliferation and increase apoptosis through inducing ER stress in colorectal cancer.
Xu K; Han B; Bai Y; Ma XY; Ji ZN; Xiong Y; Miao SK; Zhang YY; Zhou LM
Cell Death Dis; 2019 Feb; 10(3):152. PubMed ID: 30770794
[TBL] [Abstract][Full Text] [Related]
60. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer.
Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z
J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]